We deliver fully integrated, GMP-compliant turnkey cleanroom design and engineering solutions tailored specifically for cell and gene therapy (CGT) manufacturing. Covering clinical-grade pilot facilities and commercial production environments, our full-service scope encompasses master zoning planning, classified aseptic cleanroom construction, specialized utility configuration, process flow optimization, containment system integration and full validation support. Engineered to address the unique attributes of personalized, low-batch and high-risk CGT workflows—including strict microbial control, cross-contamination prevention, material traceability and highly aseptic cell manipulation—our turnkey infrastructure enables stable, reproducible and audit-ready manufacturing for CAR-T, NK cells, stem cells and viral vector production lines.
Our CGT cleanroom design is built on the core principles of strict biosafety containment, unidirectional segregated workflow, personalized process adaptability and multi-level aseptic protection. We implement hierarchical cleanroom grading and independent pressure cascade zoning to isolate cell preparation, viral vector manipulation, fill-finish and material buffer zones. Strict personnel, material and waste segregation eliminates cross-contamination risks for patient-derived biological materials. Optimized low-turbulence airflow, minimized human intervention pathways and dedicated disinfection systems ensure stable environmental cleanliness, while modular layout architecture supports flexible batch switching and future process expansion for evolving cell and gene therapy pipelines.
All cleanroom design specifications, environmental control parameters and containment strategies fully comply with FDA, EMA Annex 1, ICH Q guidelines and ISPE cell therapy manufacturing standards. We embed full-process data integrity systems compliant with 21 CFR Part 11, enabling complete traceability of environmental monitoring, process operation and batch records. Designed for rigorous bioburden control, particulate limitation and biosafety risk mitigation, our CGT cleanroom infrastructure meets global clinical trial and commercial licensing requirements, ensuring full inspection readiness for international regulatory reviews.
We provide end-to-end turnkey services from preliminary feasibility study and conceptual layout design, detailed cleanroom and utility engineering, on-site construction and system integration, to commissioning, qualification and ongoing technical support. Our single-source delivery model eliminates multi-disciplinary coordination gaps, shortens project lead time and standardizes GMP execution across the entire facility. With highly sterile, risk-controlled and process-optimized cleanroom environments, clients achieve reliable CGT product safety, consistent batch quality and accelerated clinical and commercial translation.
